Cargando…
In silico evidence of beauvericin antiviral activity against SARS-CoV-2
BACKGROUND: Scientists are still battling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus 2019 (COVID-19) pandemic so human lives can be saved worldwide. Secondary fungal metabolites are of intense interest due to their broad range of pharmaceu...
Autores principales: | Al Khoury, Charbel, Bashir, Zainab, Tokajian, Sima, Nemer, Nabil, Merhi, Georgi, Nemer, Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709726/ https://www.ncbi.nlm.nih.gov/pubmed/34968860 http://dx.doi.org/10.1016/j.compbiomed.2021.105171 |
Ejemplares similares
-
Beauvericin potentiates the activity of pesticides by neutralizing the ATP-binding cassette transporters in arthropods
por: Al Khoury, Charbel, et al.
Publicado: (2021) -
Interleukin-37: A Link Between COVID-19, Diabetes, and the Black Fungus
por: Tokajian, Sima, et al.
Publicado: (2022) -
SARS-CoV-2 genomic epidemiology: data and sequencing infrastructure
por: Merhi, Georgi, et al.
Publicado: (2022) -
SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis
por: Issa, Elio, et al.
Publicado: (2020) -
Genomic characterization and phylogenetic analysis of the first SARS-CoV-2 variants introduced in Lebanon
por: Feghali, Rita, et al.
Publicado: (2021)